SCHEMBL17188565

SCHEMBL17188565

COc1cc2c(cc1OC)C1C(=O)c3c(SI)cc4c(c3OC1CO2)C=CC(C)(C)O4

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 11/20 0.77
▸ MAPT P10636 8/20 0.77
▸ SMN1; SMN2 Q16637 8/20 0.77
▸ TDP1 Q9NUW8 5/20 0.77
▸ KDM4E B2RXH2 5/20 0.77
▸ ALDH1A1 P00352 5/20 0.77
▸ USP2 O75604 4/20 0.77
▸ MAPK1 P28482 4/20 0.77
▸ TP53 P04637 4/20 0.72
▸ CYP2C19 P33261 4/20 0.72
▸ TSHR P16473 3/20 0.72
▸ CYP1A2 P05177 2/20 0.72
▸ HSP90AA1 P07900 1/20 0.72
▸ CYP2D6 P10635 1/20 0.72
▸ ODC1 P11926 1/20 0.49
▸ HPGD P15428 2/20 0.47
▸ LMNA P02545 4/20 0.45
▸ GALR3 O60755 2/20 0.45
▸ NPC1 O15118 2/20 0.45
▸ RAB9A P51151 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14273346 0.87 CYP3A4 (0.80) CYP3A4MAPTSMN1; SMN2TDP1KDM4E
SCHEMBL11938491 0.87 CYP3A4 (0.80) CYP3A4MAPTSMN1; SMN2TDP1KDM4E
SCHEMBL11938549 0.87 CYP3A4 (0.80) CYP3A4MAPTSMN1; SMN2TDP1KDM4E
SCHEMBL19185964 0.87 CYP3A4 (0.80) CYP3A4MAPTSMN1; SMN2TDP1KDM4E
Toxicarol SCHEMBL4742046 0.87 CYP3A4 (1.00) CYP3A4MAPTSMN1; SMN2TDP1KDM4E
Toxicarol SCHEMBL25199717 0.87 CYP3A4 (1.00) CYP3A4MAPTSMN1; SMN2TDP1KDM4E
SCHEMBL11938546 0.84 CYP3A4 (0.75) CYP3A4MAPTSMN1; SMN2TDP1KDM4E
SCHEMBL11938548 0.84 CYP3A4 (0.75) CYP3A4MAPTSMN1; SMN2TDP1KDM4E
Deguelin SCHEMBL73183 0.84 CYP3A4 (1.00) CYP3A4MAPTSMN1; SMN2TDP1KDM4E
Deguelin SCHEMBL30910172 0.84 CYP3A4 (1.00) CYP3A4MAPTSMN1; SMN2TDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9161997-B2 Contrast agents for myocardial perfusion imaging LANTHEUS MEDICAL IMAGING, INC. 2015-10-20 — — US disclosed
Send feedback